Northern Lincolnshire and Goole Hospitals NHS Foundation Trust Order ePrescribing from Ascribe

AscribeAscribe announced that Northern Lincolnshire and Goole Hospitals NHS Foundation Trust have ordered Ascribe's Electronic Prescribing and Medicines Administration (ePMA) solution. The Trust has successfully used Ascribe's Web Pharmacy Solution for some time; by moving to a full ePMA solution, the Trust's clinicians can access a wider set of healthcare IT systems and improve patient safety as their clinical decisions become more fully informed.

Mike Urwin, Clinical Director of Pharmacy and Medicines Management at Northern Lincolnshire & Goole Hospitals NHS Foundation Trust said, "The introduction of e-prescribing is good news for the Trust and our patients. It enables us to implement the 'closed loop' of medicines management, allowing us to improve service delivery and improve patient safety. By using decision support during prescribing we can also enable clinicians to make the most informed decision for patients, and implement a solution that can monitor outcomes to improve the care we give to all our patients."

Ascribe ePMA improves patient safety by reducing medical and administrative errors that are linked to handwritten notes. The Trust is expecting to receive additional benefits from improved drug use reporting and cost efficiencies from their drug budget. The integrated Ascribe solution provides valuable insights into drug use and provides Trusts with a lower cost of drug ownership with improved flexibility of access.

The enterprise-wide solution will help improve communication across the healthcare team by providing a single and comprehensive source of up-to-date information relating to the management of medicines for a patient.

The Trust also uses Ascribe to provide their:

1. Patient Administration System (PAS)
2. Pharmacy stock management & clinical screening
3. Emergency Care system

Pete Wisher, Director of Diagnostics & Therapeutics at Northern Lincolnshire & Goole Hospitals NHS Foundation Trust said, "I hope that our partnership with Ascribe will enable us to better integrate our trust-wide clinical systems, both Ascribe's and additional third-party clinical systems. By connecting our systems and focusing upon the needs of our patients, we will be able to deliver safety and operational benefits."

Stephen Critchlow, CEO of Ascribe, commented on the project: "Ascribe have worked with Northern Lincolnshire and Goole for many years, and we are delighted that they have selected Ascribe to be their partner for their electronic prescribing project."

About Ascribe ePMA
Ascribe electronic Prescribing and Medicines Administration (ePMA) provides the closed loop of medicines management leading to tighter control of drug budgets, faster discharge turnaround and increased safety.

ePMA enables complex regimens to be prescribed with a single click and supports all forms of UK practice - Independent prescribing, Supplementary prescribing and Patient Group directions. Drug supply requests are instantly communicated for faster turnaround. The prescriptions are coded in such a way that they pass seamlessly to robotic dispensing and manufacturing.

The solution is designed to follow the workflow of clinicians and nurses for prescribing and administration. The system has in-built Medicines Reconciliation and supports clinical screening by pharmacists. The use of Patient's own medication is supported and drug administration can be recorded via touchscreen devices. ePMA provides an end-to-end integrated process with no transcription.

About Northern Lincolnshire and Goole Hospitals NHS Foundation Trust
Northern Lincolnshire and Goole Hospitals NHS Foundation Trust was established as a combined hospital and community Trust on 1st April 2001 and achieved Foundation Status on 1st May 2007. It was formed by the merger of North East Lincolnshire NHS Trust and Scunthorpe and Goole Hospitals NHS Trust and operates all NHS hospitals in Scunthorpe, Grimsby and Goole. Its name reflects the wider geographical area in which the Trust is a major provider of health care. The population within the area covered by the Trust is estimated at 358,000.

About Ascribe
From trust-wide EPR solutions through to individual departmental clinical systems and services, Ascribe is able to deliver IT solutions that cater to all secondary care clinical requirements. Using a professional Consultancy division, Ascribe also delivers a comprehensive range of Integration and Business Intelligence solutions based on Microsoft® & other third party IT suppliers to significantly improve clinical and operational efficiencies, to improve patient safety and reduce operating costs.

Most Popular Now

European Artificial Intelligence Act Com…

The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

Patient Safety must be Central to the De…

An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

ChatGPT Shows Promise in Answering Patie…

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

Survey: Most Americans Comfortable with …

Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

AI Spots Cancer and Viral Infections at …

Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

Video Gaming Improves Mental Well-Being

A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

New Diabetes Research Links Blood Glucos…

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

Machine learning helps identify rheumato…

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...

New AI Software could Make Diagnosing De…

Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

A New AI Tool for Cancer

Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described Sept...

Vision-Based ChatGPT Shows Deficits Inte…

Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study's results were published...

Bayer Launches New Healthy-Aging Ecosyst…

Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging...